SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-004371
Filing Date
2018-03-05
Accepted
2018-03-05 16:02:18
Documents
9
Period of Report
2018-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K EARNINGS RELEASE sndx-8k_20180305.htm 8-K 27135
2 EX-99.1 sndx-ex991_6.htm EX-99.1 223183
3 GRAPHIC g2018030517563564934478.jpg GRAPHIC 2883
4 GRAPHIC g2018030517563632334481.jpg GRAPHIC 2883
5 GRAPHIC g2018030517563632934482.jpg GRAPHIC 2883
6 GRAPHIC g2018030517563631534480.jpg GRAPHIC 2883
7 GRAPHIC g2018030517563653934484.jpg GRAPHIC 2883
8 GRAPHIC g2018030517563593434479.jpg GRAPHIC 2883
9 GRAPHIC g2018030517563639134483.jpg GRAPHIC 2883
  Complete submission text file 0001564590-18-004371.txt   280423
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 18665974
SIC: 2834 Pharmaceutical Preparations